Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

LIVN

LivaNova PLC

Dec 20 • 04:00PM ET

47.59

Dollar change +0.10
Percentage change 0.21	%

Healthcare • Medical Devices • United Kingdom • NASD

Peers: ABT MDT EW BSX SYK ZBH PODD GMED NVCR TMDX

| Held by: IJH IWM VXF IWN MDY IHI VTWO SCHA SPMD IJJ

Scroll to Statements

Index	RUT	P/E	111.66	EPS (ttm)	0.43	Insider Own	0.33%	Shs Outstand	54.30M	Perf Week	-7.59%
Market Cap	2.59B	Forward P/E	13.05	EPS next Y	3.65	Insider Trans	-1.51%	Shs Float	54.12M	Perf Month	-4.92%
Income	23.63M	PEG	-	EPS next Q	0.80	Inst Own	100.00%	Short Float	4.28%	Perf Quarter	-7.25%
Sales	1.24B	P/S	2.09	EPS this Y	19.63%	Inst Trans	-3.97%	Short Ratio	4.80	Perf Half Y	-12.60%
Book/sh	24.13	P/B	1.97	EPS next Y	8.88%	ROA	0.97%	Short Interest	2.31M	Perf Year	-4.44%
Cash/sh	12.25	P/C	3.88	EPS next 5Y	-4.60%	ROE	1.86%	52W Range	43.15 - 64.47	Perf YTD	-8.02%
Dividend Est.	-	P/FCF	23.83	EPS past 5Y	-	ROI	1.21%	52W High	-26.19%	Beta	1.00
Dividend TTM	-	Quick Ratio	2.87	Sales past 5Y	1.30%	Gross Margin	68.16%	52W Low	10.29%	ATR (14)	1.58
Dividend Ex-Date	-	Current Ratio	3.37	EPS Y/Y TTM	691.94%	Oper. Margin	11.09%	RSI (14)	34.36	Volatility	4.13% 2.92%
Employees	2900	Debt/Eq	0.52	Sales Y/Y TTM	10.69%	Profit Margin	1.91%	Recom	1.33	Target Price	71.89
Option/Short	Yes / Yes	LT Debt/Eq	0.49	EPS Q/Q	545.21%	Payout	0.00%	Rel Volume	2.88	Prev Close	47.49
Sales Surprise	5.89%	EPS Surprise	25.58%	Sales Q/Q	11.19%	Earnings	Oct 30 BMO	Avg Volume	482.31K	Price	47.59
SMA20	-5.94%	SMA50	-7.77%	SMA200	-9.93%	Trades		Volume	1,387,306	Change	0.21%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-04-24	Initiated	Goldman	Buy	$65
Sep-17-24	Upgrade	Robert W. Baird	Neutral → Outperform	$55 → $66
Mar-20-24	Reiterated	Needham	Buy
Feb-20-24	Upgrade	Mizuho	Neutral → Buy	$60 → $70
Sep-06-23	Initiated	HSBC Securities	Hold	$52
Jul-19-23	Initiated	Robert W. Baird	Neutral	$56
Apr-14-23	Initiated	Mizuho	Neutral	$48
Dec-21-22	Initiated	Barclays	Equal Weight	$62
Apr-06-22	Initiated	Wolfe Research	Outperform	$95
Feb-24-22	Upgrade	UBS	Neutral → Buy	$96
Dec-03-21	Initiated	Goldman	Buy	$108
Aug-20-21	Reiterated	Needham	Buy	$104 → $117
Jul-20-21	Upgrade	Needham	Hold → Buy	$93
Mar-03-21	Downgrade	Berenberg	Buy → Hold	$84
Jan-05-21	Downgrade	Needham	Buy → Hold
Sep-02-20	Initiated	Robert W. Baird	Outperform	$55
Jun-26-20	Reiterated	Needham	Buy	$84 → $76
Oct-30-19	Reiterated	Needham	Buy	$91 → $88
Feb-28-19	Reiterated	Needham	Buy	$135 → $120
Nov-28-18	Initiated	UBS	Neutral	$105

Show Previous Ratings

Dec-18-24 08:30AM	RECOVER Clinical Study Shows Meaningful Benefits of LivaNovas VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression (Business Wire)
Dec-05-24 09:00AM	LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting (Business Wire)
Nov-28-24 09:55AM	Wall Street Analysts Predict a 37.2% Upside in LivaNova (LIVN): Here's What You Should Know (Zacks)
Nov-14-24 09:00AM	LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences (Business Wire)
Nov-13-24 06:16AM	Livanova hits sleep apnea trial goals, plans FDA filing (MedTech Dive)
06:16AM	Loading…
06:16AM	Livanova hits goals in sleep apnea implant trial, plans FDA filing (MedTech Dive)
05:57AM	Goldman Sachs Says Improving Growth Could Propel These 2 Stocks Higher (TipRanks)
Nov-11-24 04:05PM	LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints (Business Wire)
Nov-07-24 12:00PM	LivaNova (LIVN) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
09:55AM	How Much Upside is Left in LivaNova (LIVN)? Wall Street Analysts Think 38.2% (Zacks)
Nov-03-24 01:37PM	Is a LivaNova PLC (LIVN) Promising Medical Stock with Growth Potential? (Insider Monkey)
Oct-31-24 08:31AM	Analyst Report: LivaNova PLC (Morningstar Research)
07:00AM	LivaNova PLC (LIVN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges (GuruFocus.com)
Oct-30-24 07:15AM	LivaNova (LIVN) Tops Q3 Earnings and Revenue Estimates (Zacks)
06:15AM	LivaNova: Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	Loading…
06:00AM	LivaNova Reports Third-Quarter 2024 Results (Business Wire)
Oct-09-24 03:30PM	LivaNova PLC (LIVN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Oct-08-24 09:00AM	LivaNova Appoints Susan Podlogar as a New Director (Business Wire)
Sep-25-24 09:00AM	LivaNova to Announce Third-Quarter 2024 Results (Business Wire)
Sep-14-24 01:51AM	Insider Sale: Director Francesco Bianchi Sells 1,500 Shares of LivaNova PLC (LIVN) (GuruFocus.com)
Sep-12-24 04:02PM	Analyst Report: LivaNova PLC (Morningstar Research)
Aug-28-24 07:13PM	Analyst Report: LivaNova PLC (Morningstar Research)
Aug-27-24 07:15PM	Analyst Report: LivaNova PLC (Morningstar Research)
Aug-26-24 07:15PM	Analyst Report: LivaNova PLC (Morningstar Research)
Aug-19-24 09:00AM	LivaNova to Present at the Baird Global Healthcare Conference (Business Wire)
Aug-12-24 08:12PM	Analyst Report: LivaNova PLC (Morningstar Research)
Jul-31-24 02:00PM	Analyst Report: LivaNova PLC (Morningstar Research)
07:10AM	LivaNova (LIVN) Beats Q2 Earnings and Revenue Estimates (Zacks)
06:10AM	LivaNova: Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	LivaNova Reports Second-Quarter 2024 Results (Business Wire)
09:00AM	Loading…
Jun-18-24 09:00AM	LivaNova to Announce Second-Quarter 2024 Results (Business Wire)
Jun-08-24 10:08PM	Top 50 Companies in London (Insider Monkey)
Jun-06-24 07:45PM	Analyst Report: LivaNova PLC (Morningstar Research) -12.04%
09:00AM	LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients (Business Wire)
May-23-24 09:00AM	LivaNova to Present at the Goldman Sachs Healthcare Conference (Business Wire)
May-02-24 11:50AM	LivaNova PLC (NASDAQ:LIVN) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-01-24 08:12PM	Analyst Report: LivaNova PLC (Morningstar Research) +12.32%
09:59AM	LivaNova's Q1 Adjusted Earnings, Revenue Rise, Tops Street View; Raises 2024 Guidance (MT Newswires)
07:33AM	LivaNova PLC (LIVN) Surpasses Analyst Revenue Forecasts in Q1 2024 (GuruFocus.com)
07:10AM	LivaNova (LIVN) Q1 Earnings and Revenues Top Estimates (Zacks)
06:11AM	LivaNova: Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	LivaNova Reports First-Quarter 2024 Results (Business Wire)
Apr-30-24 09:00AM	LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer (Business Wire)
Apr-26-24 12:34PM	Livanova says patient data obtained in 2023 cyberattack (MedTech Dive)
07:21AM	LivaNova gives notice of personal patient data compromised by hackers (Medical Device Network)
Apr-25-24 04:03PM	LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident (Business Wire)
Apr-24-24 10:01AM	LivaNova (LIVN) Earnings Expected to Grow: Should You Buy? (Zacks)
Mar-21-24 09:00AM	LivaNova to Announce First-Quarter 2024 Results (Business Wire)
04:46AM	LivaNova (LIVN) Soars 12.5%: Is Further Upside Left in the Stock? (Zacks)
Mar-20-24 09:00AM	LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea (Business Wire) +12.50%
Mar-05-24 09:55PM	LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029 (Business Wire) -6.21%
Mar-04-24 04:44PM	LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes (Business Wire)
09:00AM	LivaNova to Present at the Barclays Global Healthcare Conference (Business Wire)
Feb-22-24 09:58AM	LivaNova PLC (NASDAQ:LIVN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-21-24 03:15PM	Analyst Report: LivaNova PLC (Morningstar Research) +8.02%
07:10AM	LivaNova (LIVN) Q4 Earnings and Revenues Top Estimates (Zacks)
06:32AM	LivaNova PLC (LIVN) Posts Double-Digit Revenue Growth in Q4 and Full-Year 2023 (GuruFocus.com)
06:11AM	LivaNova: Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	LivaNova Reports Fourth-Quarter and Full-Year 2023 Results (Business Wire)
Feb-13-24 01:04PM	PRIMECAP Management Bolsters Stake in LivaNova PLC (GuruFocus.com)
Feb-09-24 04:34AM	Livanova to lay off 137 people at Pittsburgh facility (MedTech Dive)
Feb-06-24 06:15AM	Livanova names J&J veteran Vladimir Makatsaria as CEO (MedTech Dive)
Feb-05-24 08:00AM	LivaNova Announces Vladimir A. Makatsaria as CEO and Board Director (Business Wire)
Jan-10-24 05:00AM	Livanova to close loss-making circulatory support business (MedTech Dive)
Jan-08-24 08:30AM	LivaNova to Wind Down Advanced Circulatory Support Business Unit (Business Wire) +6.89%
Jan-04-24 09:00AM	LivaNova to Announce Fourth-Quarter and Full-Year 2023 Results (Business Wire)
Dec-12-23 08:02PM	Analyst Report: LivaNova PLC (Morningstar Research) +7.58%
Dec-05-23 09:39AM	Billionaire David Einhorns 10 Stock Picks with Huge Upside Potential (Insider Monkey)
Nov-27-23 06:04AM	LivaNova warns cybersecurity incident disrupts systems, takes steps to limit impact (MedTech Dive)
Nov-24-23 02:19PM	15 Stocks Billionaire David Einhorn Just Bought and Sold (Insider Monkey)
Nov-22-23 07:55PM	Analyst Report: LivaNova PLC (Morningstar Research)
Nov-09-23 09:00AM	LivaNova to Present at the Piper Sandler Healthcare Conference (Business Wire)
Nov-02-23 02:48PM	LivaNova PLC (NASDAQ:LIVN) Q3 2023 Earnings Call Transcript (Insider Monkey)
08:52AM	Analyst Report: LivaNova PLC (Morningstar Research)
Nov-01-23 09:36AM	LivaNova PLC (LIVN) Reports 13.3% Increase in Q3 Revenue (GuruFocus.com)
06:13AM	LivaNova: Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	LivaNova Reports Third-Quarter 2023 Results (Business Wire)
Oct-25-23 09:00AM	LivaNova to Present at the Stifel and Wolfe Healthcare Conferences (Business Wire)
Oct-06-23 08:30AM	LivaNova Board Appoints J. Christopher Barry as New Director (Business Wire)
Sep-25-23 06:01PM	Analyst Report: LivaNova PLC (Morningstar Research)
Sep-21-23 07:00AM	LivaNova Announces Marco Dolci, President of Cardiopulmonary, to Retire at the End of 2023 (Business Wire)
Sep-20-23 09:00AM	LivaNova to Announce Third-Quarter 2023 Results (Business Wire)
Sep-05-23 09:46AM	LivaNova (LIVN) Advances Cardiopulmonary Wing With Essenz ILBM (Zacks)
Aug-30-23 04:05PM	LivaNova Unveils Essenz In-Line Blood Monitor with U.S. FDA 510(k) Clearance and CE Mark (Business Wire)
Aug-24-23 09:00AM	LivaNova to Present at the Baird Global Healthcare Conference (Business Wire)
Jul-26-23 05:21PM	Analyst Report: LivaNova PLC (Morningstar Research) +9.87%
07:15AM	LivaNova (LIVN) Q2 Earnings and Revenues Beat Estimates (Zacks)
06:04AM	LivaNova: Q2 Earnings Snapshot (AP Finance)
06:00AM	LivaNova Reports Second-Quarter 2023 Results (Business Wire)
Jul-03-23 03:11PM	Is It Too Late To Consider Buying LivaNova PLC (NASDAQ:LIVN)? (Simply Wall St.)
05:13AM	Is LivaNova PLC (LIVN) a Good Value Stock? (Insider Monkey)
Jun-21-23 08:00PM	LIVN: Raising target price to $53.00 (Argus Research)
Jun-17-23 10:20AM	Is There An Opportunity With LivaNova PLC's (NASDAQ:LIVN) 34% Undervaluation? (Simply Wall St.)
Jun-14-23 09:00AM	LivaNova to Announce Second-Quarter 2023 Results (Business Wire)
Jun-13-23 09:00AM	LivaNova Announces 150th Bipolar Depression Patient Randomized in RECOVER Clinical Study (Business Wire)
May-29-23 11:53AM	Shareholders in LivaNova (NASDAQ:LIVN) have lost 54%, as stock drops 3.8% this past week (Simply Wall St.)
May-18-23 07:17AM	David Einhorns 2023 Portfolio: Top 15 Stock Picks (Insider Monkey)
May-08-23 09:51AM	LivaNova PLC's (NASDAQ:LIVN) Share Price Is Matching Sentiment Around Its Revenues (Simply Wall St.)
May-03-23 07:25AM	LivaNova (LIVN) Beats Q1 Earnings and Revenue Estimates (Zacks)
06:14AM	LivaNova: Q1 Earnings Snapshot (AP Finance)

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). The Cardiopulmonary segment is involved in the design, development, manufacture, marketing and selling of cardiopulmonary products. The Neuromodulation segment is associated in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating DRE and DTD. The ACS segment deals with the design, development, manufacture, marketing and selling of temporary life support products. The company was founded in 1987 and is headquartered in London, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hutchinson Michael Damon	Chief Legal Officer	Dec 15 '24	Option Exercise	0.00	2,254	0	4,540	Dec 17 05:23 PM
Poletti Franco	President, Cardiopulmonary	Dec 15 '24	Option Exercise	0.00	967	0	7,634	Dec 17 05:23 PM
Barry James Christopher	Director	Dec 15 '24	Option Exercise	0.00	1,709	0	1,709	Dec 17 05:22 PM
Shvartsburg Alex	Chief Financial Officer	Dec 15 '24	Option Exercise	0.00	613	0	19,342	Dec 17 05:22 PM
Bianchi Francesco	Director	Dec 11 '24	Sale	50.99	1,250	63,738	7,522	Dec 13 04:03 PM
Bianchi Francesco	Director	Dec 11 '24	Proposed Sale	50.99	1,250	63,738		Dec 11 04:40 PM
Hebbelinck Trui	Officer	Dec 10 '24	Proposed Sale	50.27	6,000	301,621		Dec 10 05:30 PM
Bianchi Francesco	Director	Sep 11 '24	Sale	46.58	1,500	69,870	8,772	Sep 13 04:13 PM
Bianchi Francesco	Director	Sep 11 '24	Proposed Sale	46.58	1,500	69,870		Sep 11 04:58 PM
WILVER PETER M	Director	Jun 15 '24	Option Exercise	0.00	2,680	0	4,317	Jun 18 04:06 PM
Enxing Seng Stacy	Director	Jun 15 '24	Option Exercise	0.00	2,680	0	9,330	Jun 18 04:06 PM
Shvartsburg Alex	CFO	Jun 15 '24	Option Exercise	0.00	1,576	0	19,399	Jun 18 04:06 PM
Bianchi Francesco	Director	Jun 15 '24	Option Exercise	0.00	2,680	0	10,857	Jun 18 04:06 PM
SCHERMERHORN TODD C	Director	Jun 15 '24	Option Exercise	0.00	2,680	0	6,643	Jun 18 04:05 PM
O'Kane Sharon	Director	Jun 15 '24	Option Exercise	0.00	2,680	0	10,754	Jun 18 04:05 PM
Story Brooke	Director	Jun 15 '24	Option Exercise	0.00	2,680	0	4,060	Jun 18 04:05 PM
Moore Daniel Jeffrey	Director	Jun 03 '24	Option Exercise	57.39	56,623	3,249,594	84,157	Jun 05 04:03 PM
Moore Daniel Jeffrey	Director	Jun 03 '24	Sale	60.11	56,623	3,403,694	27,534	Jun 05 04:03 PM
Bolton Stephanie	President, Global Epilepsy	Mar 30 '24	Option Exercise	0.00	7,744	0	13,205	Apr 02 09:22 PM
Hebbelinck Trui	Chief Human Resources Officer	Mar 30 '24	Option Exercise	0.00	11,779	0	19,320	Apr 02 09:21 PM
Shvartsburg Alex	CFO	Mar 30 '24	Option Exercise	0.00	14,752	0	24,133	Apr 02 09:20 PM
Hutchinson Michael Damon	Chief Legal Officer	Mar 30 '24	Option Exercise	0.00	1,478	0	2,828	Apr 02 09:18 PM
KOZY WILLIAM A	Chairman and CEO	Feb 29 '24	Option Exercise	0.00	14,512	0	32,333	Mar 04 05:22 PM
Saia Andrea Lynn	Director	Dec 31 '23	Option Exercise	0.00	1,468	0	11,113	Jan 03 04:14 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LIVN

LivaNova PLC

Upgrade your FINVIZ experience